Lung Cancer Diagnostic And Screening Industry Insights: Market Forecast to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Lung Cancer Diagnostic And Screening Market Size Likely To Evolve From 2025 Through 2034?

The lung cancer diagnostic and screening market size has shown strong growth in recent years. It is anticipated to increase from $2.34 billion in 2024 to $2.56 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.4%. This historical growth can be ascribed to advancements such as the expansion of digital imaging, the standardization of screening protocols, public health initiatives targeting tobacco use, the establishment of cancer registries, and improvements in pathology analysis.

The market for lung cancer diagnostics and screening is anticipated to experience substantial expansion in the coming years. By 2029, it is projected to reach “$3.68 billion”, demonstrating a compound annual growth rate (CAGR) of 9.5%. This growth during the forecast period can be primarily attributed to factors such as the rising incidence of lung cancer, a heightened focus on early detection, the expansion of high-risk screening initiatives, the evolving trend towards personalized medicine, and various government initiatives and funding efforts. Significant trends anticipated in this period encompass the development of new screening methods, progress in biomarker testing, the incorporation of artificial intelligence (AI), an increase in the adoption of liquid biopsy, a concentrated effort on identifying cancer at early stages, and the broadening of low-dose CT screening programs.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12043&type=smp

What Are The Drivers Pushing New Developments In The Lung Cancer Diagnostic And Screening Market?

An anticipated rise in lung cancer cases is projected to boost the expansion of the lung cancer diagnostic and screening market in the coming years. This severe illness, marked by the uncontrolled multiplication of irregular cells within lung tissues, presents with indications like coughing, chest pain, and impaired breathing. Early detection of this condition in patients is facilitated by lung cancer diagnosis and screening, utilizing diverse procedures such as an incisional biopsy and a bronchoscopy. As an illustration, data from January 2023, released by the American Cancer Society, a US-based government organization, revealed approximately 238,340 new cases of lung cancer in the United States (comprising 117,550 in men and 120,790 in women). Additionally, 127,070 deaths attributed to lung cancer were reported (with 67,160 among men and 59,910 among women). Consequently, the increasing incidence of lung cancer is a key factor propelling the expansion of the lung cancer diagnostic and screening market.

What Are The Major Segments Identified In The Lung Cancer Diagnostic And Screening Market?

The lung cancer diagnostic and screeningmarket covered in this report is segmented –

1) By Product: Instruments; Consumables And Accessories

2) By Test: Biomarkers Tests; Imaging Test; Biopsy; Blood Test; Other Tests

3) By Cancer Type: Non-Small Cell Lung Cancer; Small Cell Lung Cancer

4) By End User: Hospital; Independent Diagnostic Laboratories; Diagnostic Imaging Centers; Cancer Research Institutes; Other End-Users

Subsegments:

1) By Instruments: Imaging Devices; Biopsy Devices; Bronchoscopy Systems

2) By Consumables And Accessories: Biopsy Needles; Reagents And Assays; Imaging Contrast Agents; Patient Preparation Equipment; Sample Collection Kits; Laboratory Supplies

Which Ongoing Trends Are Expected To Shape The Lung Cancer Diagnostic And Screening Market Outlook?

Leading firms within the lung cancer diagnostic and screening sector are innovating technologies, including specific lung cancer tests, to improve early identification, refine diagnostic precision, and enable tailored treatment strategies for individuals highly susceptible to the illness. These lung cancer tests function as diagnostic tools, employing diverse methodologies such as imaging techniques, biomarker assessments, and cytological studies, to identify the existence of the disease. As an illustration, Freenome, a US biotechnology enterprise, introduced PROACT LUNG in December 2023. The PROACT LUNG trial offers a significant advancement set to transform lung cancer screening, with the potential to achieve earlier diagnoses and superior patient results, concurrently bridging current screening deficiencies.

Who Are The Key Multinational Companies Dominating The Lung Cancer Diagnostic And Screening Market?

Major companies operating in the lung cancer diagnostic and screening market include Pfizer Inc., F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca Plc, Abbott Laboratories Inc., Danaher Corporation, Siemens Healthcare GmbH, FUJIFILM Corporation, Koninklijke Philips N.V., GE Healthcare Bio Sciences AB, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Qiagen Inc., Myriad Genetic Laboratories Inc., NeoGenomics Laboratories Inc., Canon Medical Systems Corporation, OncimmuneHoldings Plc, Broncus Medical Inc., OncoCyte, Riverain Technologies LLC, VisionGate, Foundation Medicine Inc., Biodesix,

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/lung-cancer-diagnostic-and-screening-global-market-report

What Are The Key Regional Factors Influencing The Lung Cancer Diagnostic And Screening Market Growth?

North America was the largest region in the lung cancer diagnostic and screening market in 2024. The regions covered in the lung cancer diagnostic and screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Lung Cancer Diagnostic And Screening Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12043&type=smp

Browse Through More Reports Similar to the Global Lung Cancer Diagnostic And Screening Market 2025, By The Business Research Company

Cold Chain Packaging Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cold-chain-packaging-global-market-report

Pharmaceutical Logistics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-logistics-global-market-report

Chemicals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chemicals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795